IT1264321B - Esteri di acidi pectici e pectinici, procedimento di preparazione e loro applicazioni farmaceutiche e biosanitarie - Google Patents

Esteri di acidi pectici e pectinici, procedimento di preparazione e loro applicazioni farmaceutiche e biosanitarie

Info

Publication number
IT1264321B
IT1264321B ITPD920004A ITPD920004A IT1264321B IT 1264321 B IT1264321 B IT 1264321B IT PD920004 A ITPD920004 A IT PD920004A IT PD920004 A ITPD920004 A IT PD920004A IT 1264321 B IT1264321 B IT 1264321B
Authority
IT
Italy
Prior art keywords
pharmaceutical
pectic
esters
biosanitary
applications
Prior art date
Application number
ITPD920004A
Other languages
English (en)
Inventor
Vittorio Crescenzi
Lanfranco Callegaro
Original Assignee
Mini Ricerca Scient Tecnolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11389767&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1264321(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mini Ricerca Scient Tecnolog filed Critical Mini Ricerca Scient Tecnolog
Priority to ITPD920004A priority Critical patent/IT1264321B/it
Publication of ITPD920004A0 publication Critical patent/ITPD920004A0/it
Priority to AT93902199T priority patent/ATE171463T1/de
Priority to PCT/EP1993/000075 priority patent/WO1993014129A1/en
Priority to JP51214793A priority patent/JP3717924B2/ja
Priority to EP93902199A priority patent/EP0621877B2/en
Priority to AU42641/93A priority patent/AU4264193A/en
Priority to DE69321215T priority patent/DE69321215T3/de
Priority to US08/003,732 priority patent/US5384400A/en
Publication of ITPD920004A1 publication Critical patent/ITPD920004A1/it
Publication of IT1264321B publication Critical patent/IT1264321B/it
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231—Pectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/025—Explicitly spheroidal or spherical shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invenzione concerne esteri totali e parziali di acidi pectici e pectinici (PGA e PGA-Me-x%), relativi metodi di preparazione, preparazioni farmaceutiche e/o medicamenti e loro impiego in campo farmaceutico, biomedico, alimentare e cosmetico.-
ITPD920004A 1992-01-13 1992-01-13 Esteri di acidi pectici e pectinici, procedimento di preparazione e loro applicazioni farmaceutiche e biosanitarie IT1264321B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITPD920004A IT1264321B (it) 1992-01-13 1992-01-13 Esteri di acidi pectici e pectinici, procedimento di preparazione e loro applicazioni farmaceutiche e biosanitarie
DE69321215T DE69321215T3 (de) 1992-01-13 1993-01-12 Ester aus pektin und pektinische säure
JP51214793A JP3717924B2 (ja) 1992-01-13 1993-01-12 ペクチン酸およびペクチニン酸のエステル体
PCT/EP1993/000075 WO1993014129A1 (en) 1992-01-13 1993-01-12 Esters of pectic and pectinic acid
AT93902199T ATE171463T1 (de) 1992-01-13 1993-01-12 Ester aus pektin und pektinische saure
EP93902199A EP0621877B2 (en) 1992-01-13 1993-01-12 Esters of pectic and pectinic acid
AU42641/93A AU4264193A (en) 1992-01-13 1993-01-12 Esters of pectic and pectinic acid
US08/003,732 US5384400A (en) 1992-01-13 1993-01-13 Esters of pectic and pectinic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD920004A IT1264321B (it) 1992-01-13 1992-01-13 Esteri di acidi pectici e pectinici, procedimento di preparazione e loro applicazioni farmaceutiche e biosanitarie

Publications (3)

Publication Number Publication Date
ITPD920004A0 ITPD920004A0 (it) 1992-01-13
ITPD920004A1 ITPD920004A1 (it) 1993-07-14
IT1264321B true IT1264321B (it) 1996-09-23

Family

ID=11389767

Family Applications (1)

Application Number Title Priority Date Filing Date
ITPD920004A IT1264321B (it) 1992-01-13 1992-01-13 Esteri di acidi pectici e pectinici, procedimento di preparazione e loro applicazioni farmaceutiche e biosanitarie

Country Status (8)

Country Link
US (1) US5384400A (it)
EP (1) EP0621877B2 (it)
JP (1) JP3717924B2 (it)
AT (1) ATE171463T1 (it)
AU (1) AU4264193A (it)
DE (1) DE69321215T3 (it)
IT (1) IT1264321B (it)
WO (1) WO1993014129A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000158A1 (en) * 1993-06-25 1995-01-05 Bio-Sphere Technology Dietary supplement incorporating beta-sitosterol and pectin
IT1263394B (it) * 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
PL182804B1 (pl) * 1995-02-07 2002-03-29 Fidia Advanced Biopolymers Sposób powlekania powierzchni przedmiotu kwasem hialuronowym lub pochodną kwasu hialuronowego i sposób powlekania powierzchni przedmiotu polimerem półsyntetycznym
PE20060468A1 (es) * 2004-04-26 2006-07-06 Cp Kelco Aps Composicion dermoprotectora para controlar la alcalinidad de la piel que comprende polisacaridos de acido carboxilico
US20070092622A1 (en) * 2005-10-25 2007-04-26 Trudsoe Jens E Composition containing pectin ester
US20070098870A1 (en) * 2005-10-27 2007-05-03 Trudsoe Jens E Composition containing alkylene oxide derivative of pectin
US9815912B2 (en) * 2012-03-19 2017-11-14 University Of Massachusetts Hydrophilic modification of water insoluble polysaccharide as surface-active agents
EP2938348A4 (en) * 2012-12-30 2016-07-27 Hadasit Med Res Service ALGINATE COMPOSITIONS AND USES THEREOF
KR20210045453A (ko) * 2018-08-17 2021-04-26 세페이드 핵산 오염 제거 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL63942C (it) *
US2960498A (en) * 1956-04-02 1960-11-15 Burke Oliver W Jun Partial glycerol esters of pectic substances and preparation thereof
US3326760A (en) * 1966-05-17 1967-06-20 Synergistics Inc Choline salicylate polygalacturonate therapy
JPS4939192A (it) * 1972-08-18 1974-04-12
JPS5023671A (it) * 1973-07-02 1975-03-13
SU584012A1 (ru) * 1976-02-05 1977-12-15 Институт органической химии АН Киргизской ССР Способ получени пектата глицерина
JPS58186491A (ja) * 1982-04-19 1983-10-31 Hayashibara Biochem Lab Inc ミカン缶詰廃液の処理方法及びミカン缶詰廃液からペクチン質を製造する方法
US5008254A (en) * 1982-09-03 1991-04-16 Weibel Michael K Sugar beet pectins and their use in comestibles
US5071970A (en) * 1988-11-23 1991-12-10 University Of Florida Process for producing pectin with a high-to-medium methoxyl content from beet pulp

Also Published As

Publication number Publication date
EP0621877B1 (en) 1998-09-23
ATE171463T1 (de) 1998-10-15
DE69321215T3 (de) 2002-12-12
DE69321215D1 (de) 1998-10-29
AU4264193A (en) 1993-08-03
ITPD920004A1 (it) 1993-07-14
US5384400A (en) 1995-01-24
JPH07508542A (ja) 1995-09-21
EP0621877A1 (en) 1994-11-02
DE69321215T2 (de) 1999-06-02
EP0621877B2 (en) 2002-04-24
JP3717924B2 (ja) 2005-11-16
ITPD920004A0 (it) 1992-01-13
WO1993014129A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
ES2001512A6 (es) Procedimiento para la fabricacion de esteres totales y parciales del acido hialuronico
DK1032363T3 (da) Leveringssystem med konjugeret linolsyre i kosmetiske præparater
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
NO307031B1 (no) Farmasøytiske produkter for legning av tumorsykdommer, og fremgangsmåte for fremstilling av disse
PL261349A1 (en) Method of obtaining an incorporative complex of 7-isopropoxyisoflavone with cyclodextrin
MX9501848A (es) Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
AU1937395A (en) Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
IT1264321B (it) Esteri di acidi pectici e pectinici, procedimento di preparazione e loro applicazioni farmaceutiche e biosanitarie
HUP9900819A1 (hu) Biciklusos aromás vegyületek, alkalmazásuk a humán- és állatgyógyászatban és a kozmetikában
ITPD920142A1 (it) Esteri di gellano autoreticolato, procedimento di preparazione e loro applicazioni farmaceutiche e biomedico-sanitarie
CA2163197A1 (en) Tri(platinum) complexes
HU907959D0 (en) Medical preparations
IT8720389A0 (it) Esteri retinoici di antibiotici, loro procedimento di preparazione e composizioni farmaceutiche e cosmetiche che li contengono.
IT1184729B (it) Prodotti farmaceutico cosmetico,in particolare per la cura di acne e seborrea
DE69800804D1 (de) Halbfeste pharmazeutische zubereitungen enthaltend dexketoprofen-trometamol
IT8720438A0 (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato, loro procedimento di preparazione e loro composizioni farmaceutiche.
MY114218A (en) The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations.
FR2768731B1 (fr) Derives insatures en position -4 du 6-tert-butyl-1,1- dimethylindane et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique
ES2063056T3 (es) Esteres poliaromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
ATE255890T1 (de) Pantothensäure-enthaltende arzneimittel zur behandlung von entzündlichen gelenkserkrankungen
DE60322871D1 (de) Thaltende zubereitungen
ES2063765T3 (es) Esteres cicloalifaticos insaturados de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
IT1240348B (it) Procedimento ed apparecchiatura per la produzione di contenitori e oggetti sterili in genere, particolarmente per uso farmaceutico
IT1227158B (it) Esteri dell'acido tiamorfolinone carbossilico e di suoi derivati, loro procedimento di preparazione e loro impiego nel settore cosmetico e nel settore dermo farmaceutico.
ITMI922533A0 (it) Acidi omega-amminoalchiltartronici e loro esteri,procedimento per la loro preparazione e loro uso nella terapia del dismetabolismo osseo

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990210